qHTS to Identify Activators and Inhibitors of Wip1
qHTS to Identify Activators and Inhibitors of Wip1
批准号:
10255280
负责人:
Matthew Hall
金额:
$11.24万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
ApoptoticBindingBiological AssayChemicalsClinicalDNA DamageEnvironmentFamilyFluorescenceHumanLibrariesMalignant NeoplasmsMass Spectrum AnalysisPPM1D genePharmaceutical ChemistryPowder dose formProtein Serine/Threonine PhosphataseProteinsReporterSurface Plasmon ResonanceTP53 geneanticancer treatmentenzyme mechanismhigh throughput screeninginhibitor/antagonistmembernoveloutcome forecastoverexpressionprotein phosphatase 2Cresponsescreeningsmall moleculesmall molecule librariestherapeutic developmenttumor growth
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The overall objective of this project is to develop potent, selective, and bioactive small molecule modulators of Wip1 for use as chemical probes and starting points for therapeutic development.
During this period, the project team performed high-throughput screening against NCATS annotated libraries and diverse chemical library using a RapidFire mass spectrometry assay. The primary screening hits were further evaluated by a variety of additional assays to characterize their activities, including fluorescence reporter orthogonal assay, and binding studies by surface plasmon resonance (SPR). Currently powder order has been placed for the top ranking chemotypes/singletons and additional efforts have focused on detailed mechanistic studies of the enzymes mechanism of action, which could be exploited during medicinal chemistry optimization of chemical leads.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
BRD4 Inhibitors as Potential Therapeutics for Oncology
-
批准号:9551899
-
项目类别:
-
资助金额:$25.16万
-
财政年份:--
-
负责人:Matthew Hall
-
依托单位:
qHTS to Identify Inhibitors of Mutant and Wildtype NSD2
-
批准号:9359919
-
项目类别:
-
资助金额:$3.75万
-
财政年份:--
-
负责人:Matthew Hall
-
依托单位:
qHTS to Identify Activators and Inhibitors of Wip1
-
批准号:9551889
-
项目类别:
-
资助金额:$4.47万
-
财政年份:--
-
负责人:Matthew Hall
-
依托单位:
qHTS to Identify Inducers of Oligodendrocyte-precursor cell (OPC) Remyelination
-
批准号:9205679
-
项目类别:
-
资助金额:$1.9万
-
财政年份:--
-
负责人:Matthew Hall
-
依托单位:
qHTS to Identify Activators of hTERT
-
批准号:9358274
-
项目类别:
-
资助金额:$3.75万
-
财政年份:--
-
负责人:Matthew Hall
-
依托单位:
qHTS to Identify Compounds against Merkel Cell Carcinoma (MCC)
-
批准号:9553320
-
项目类别:
-
资助金额:$13.57万
-
财政年份:--
-
负责人:Matthew Hall
-
依托单位:
Development of small molecule modulators of WDR5/MLL1 protein-protein binding (Chemical Biology Consortium/NCI Experimental Therapeutics Collaboration)
-
批准号:9551927
-
项目类别:
-
资助金额:$25.16万
-
财政年份:--
-
负责人:Matthew Hall
-
依托单位:
qHTS to Identify Inhibitors of the Arf GTPase-activating Protein ASAP1
-
批准号:9359872
-
项目类别:
-
资助金额:$12.2万
-
财政年份:--
-
负责人:Matthew Hall
-
依托单位:
qHTS to Identify Inhibitors of NNMT1
-
批准号:10000751
-
项目类别:
-
资助金额:$25.03万
-
财政年份:--
-
负责人:Matthew Hall
-
依托单位:
Canvass: revitalizing and advancing the translation of natural products research
-
批准号:10001307
-
项目类别:
-
资助金额:$4.76万
-
财政年份:--
-
负责人:Matthew Hall
-
依托单位:
Synthesis of non-brain-permeant inhibitor of LZK
-
批准号:10001308
-
项目类别:
-
资助金额:$13.27万
-
财政年份:--
-
负责人:Matthew Hall
-
依托单位:
NPC/MIPE Toxicity Screen of IDH1 Inhibitors against Cholangiocarcinoma Cell Lines
-
批准号:10004990
-
项目类别:
-
资助金额:$25.03万
-
财政年份:--
-
负责人:Matthew Hall
-
依托单位:
qHTS to Identify Small Molecule GUS Inhibitors
-
批准号:10005006
-
项目类别:
-
资助金额:$4.76万
-
财政年份:--
-
负责人:Matthew Hall
-
依托单位:
qHTS to Identify Differentiators of Brown Adipocytes
-
批准号:10004996
-
项目类别:
-
资助金额:$13.27万
-
财政年份:--
-
负责人:Matthew Hall
-
依托单位:
High-throughput screening for small molecules demonstrating toxicity against human neuroendocrine tumor cell lines
-
批准号:10005001
-
项目类别:
-
资助金额:$13.27万
-
财政年份:--
-
负责人:Matthew Hall
-
依托单位:
Identification of brain-permeant small molecule modulators of GAL1R receptor
-
批准号:10005003
-
项目类别:
-
资助金额:$4.76万
-
财政年份:--
-
负责人:Matthew Hall
-
依托单位:
qHTS to Identify Inhibitors of NNMT1
-
批准号:10255295
-
项目类别:
-
资助金额:$30.57万
-
财政年份:--
-
负责人:Matthew Hall
-
依托单位:
qHTS to Identify Small Molecule GUS Inhibitors
-
批准号:10689615
-
项目类别:
-
资助金额:$14.62万
-
财政年份:--
-
负责人:Matthew Hall
-
依托单位:
Development of inhibitors of biliverdin reductase for toxic hyperbilirubinemia
-
批准号:10916063
-
项目类别:
-
资助金额:$12.58万
-
财政年份:--
-
负责人:Matthew Hall
-
依托单位:
Identification of Inhibitors of Yes1 Kinase Activity and Determination of Yes1 Polypharmacology of Kinase Inhibitors
-
批准号:9359863
-
项目类别:
-
资助金额:$3.75万
-
财政年份:--
-
负责人:Matthew Hall
-
依托单位:
国内基金
海外基金
登录
查看更多内容
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:32170319
-
项目类别:面上项目
-
资助金额:58.00万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:--
-
项目类别:--
-
资助金额:58万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究
-
批准号:31672538
-
项目类别:面上项目
-
资助金额:62.0万元
-
批准年份:2016
-
负责人:孙跃峰
-
依托单位:
番茄EIN3-binding F-box蛋白2超表达诱导单性结实和果实成熟异常的机制研究
-
批准号:31372080
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2013
-
负责人:杨迎伍
-
依托单位:
P53 binding protein 1 调控乳腺癌进展转移及化疗敏感性的机制研究
-
批准号:81172529
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2011
-
负责人:杨其峰
-
依托单位:
DBP(Vitamin D Binding Protein)在多发性硬化中的作用和相关机制的蛋白质组学研究
-
批准号:81070952
-
项目类别:面上项目
-
资助金额:35.0万元
-
批准年份:2010
-
负责人:刘师莲
-
依托单位:
研究EB1(End-Binding protein 1)的癌基因特性及作用机制
-
批准号:30672361
-
项目类别:面上项目
-
资助金额:24.0万元
-
批准年份:2006
-
负责人:徐宁志
-
依托单位: